Today's Reuters Health News Headlines - Yahoo! News:
|
|
Exclusive: Key figure in Olympus scandal found in Hong Kong
Sun,27 Nov 2011 06:21 AM PST
Reuters -  HONG KONG (Reuters) - Reuters found a Japanese banker who is a key figure in the Olympus Corp accounting scandal at a luxury apartment block in Hong Kong on Sunday, where he exploded in anger at finally being tracked down. Akio Nakagawa's boutique U.S. investment firm earned a $687 million fee from Olympus for a 2008 deal that made it the biggest advisory payment in history, and which the Japanese camera maker now admits was used to hide investment losses. The whereabouts of the former PaineWebber banker had been unknown until Sunday. ...
Full Story | Top |
Elan to create research centre with Cambridge University
Sun,27 Nov 2011 01:14 AM PST
Reuters - DUBLIN (Reuters) - Elan Corp Plc has signed an agreement with Britain's Cambridge University to create a research center focused on therapies for Alzheimer's and Parkinson's, the Dublin-headquartered biotech group said on Sunday. Elan, whose main research facility is in San Francisco, will spend $10 million over the next five years on the research center and has an option to extend the deal for another five years. Researchers from Cambridge and Elan want to discover ways of altering the behavior of proteins that can spread neurodegenerative disorders such as Alzheimer's and Parkinson's. ... Full Story | Top |
Libyan women demand support for war rape victims
Sat,26 Nov 2011 07:08 AM PST
Reuters -  TRIPOLI (Reuters) - About 100 Libyan women took to Tripoli's streets on Saturday in a silent march to demand more support from the country's new government for victims of rape during the eight-month war that ousted Muammar Gaddafi. Their mouths covered with duct tape, women both young and old marched for an hour to Prime Minister Abdurrahim El-Keib's office and later met him to discuss their demands. ...
Full Story | Top |
Japan reconsiders boardroom rules amid Olympus scandal
Fri,25 Nov 2011 08:41 PM PST
Reuters -  TOKYO (Reuters) - A Japanese government panel will propose mandatory appointments of outside directors on boards of large firms in the hope of averting the kind of accounting scandal that has engulfed Olympus Corp. But expectations of meaningful change are not high, and experts say the process in which companies pick outside directors may also need regulatory adjustment. The British ex-CEO of Olympus, Michael Woodford, emerged from a meeting of directors on Friday convinced its board would eventually quit. ...
Full Story | Top |
Athletes' injury-prevention programs need time
Fri,25 Nov 2011 04:26 PM PST
Reuters -  NEW YORK (Reuters Health) - Programs aimed at preventing knee injuries among soccer players take time to make any lasting impact on the way athletes move, according to a new study. A warm-up program of stretching and strengthening that lasted three months had only a temporary benefit, while the improvements seen after a nine-month program persisted for months after the training ended. "Most injury prevention programs are probably for 10 to 12 weeks. ...
Full Story | Top |
Ovary removal not tied to increased risk of death
Fri,25 Nov 2011 04:26 PM PST
Reuters - NEW YORK (Reuters Health) - Despite concerns that removing both of a woman's ovaries would raise her chances of dying from diseases associated with aging, a large new study suggests the procedure may be safe. Looking at data on more than 130,000 California teachers, researchers found that women who were 45 years old or older when they had both ovaries removed had a slightly lower chance of dying over the length of the study than peers who didn't have the procedure. ... Full Story | Top |
Heart patients prefer longevity over quality of life
Fri,25 Nov 2011 04:25 PM PST
Reuters - NEW YORK (Reuters Health) - When an elderly person's chronic disease is impossible to cure, many doctors might assume that patient would chose to improve the quality of his or her remaining life rather than to extend it as is. Those doctors would be mistaken most of the time, according to a new study. Swiss researchers who surveyed more than 500 elderly heart failure patients found three quarters wouldn't trade a longer life with symptoms for a shorter life without them, and the severity of symptoms was not a good predictor of who would pick a measure of relief over more time. ... Full Story | Top |
Low vitamin D linked to heart disease, death
Fri,25 Nov 2011 04:25 PM PST
Reuters - NEW YORK (Reuters Health) - In people with low blood levels of vitamin D, boosting them with supplements more than halved a person's risk of dying from any cause compared to someone who remained deficient, in a large new study. Analyzing data on more than 10,000 patients, University of Kansas researchers found that 70 percent were deficient in vitamin D and they were at significantly higher risk for a variety of heart diseases. D-deficiency also nearly doubled a person's likelihood of dying, whereas correcting the deficiency with supplements lowered their risk of death by 60 percent. ... Full Story | Top |
Mediterranean-ish diet tied to better heart health
Fri,25 Nov 2011 04:24 PM PST
Reuters -  NEW YORK (Reuters Health) - Once again, eating a diet based on fish, legumes, vegetables and moderate amounts of alcohol is linked to lower chances of dying from a heart attack, stroke or other vascular "events," according to a new study of New York City residents. ...
Full Story | Top |
Heart patients prefer longevity over quality of life
Fri,25 Nov 2011 03:56 PM PST
Reuters - NEW YORK (Reuters Health) - When an elderly person's chronic disease is impossible to cure, many doctors might assume that patient would chose to improve the quality of his or her remaining life rather than to extend it as is. Those doctors would be mistaken most of the time, according to a new study. Swiss researchers who surveyed more than 500 elderly heart failure patients found three quarters wouldn't trade a longer life with symptoms for a shorter life without them, and the severity of symptoms was not a good predictor of who would pick a measure of relief over more time. ... Full Story | Top |
Low vitamin D linked to heart disease, death
Fri,25 Nov 2011 03:48 PM PST
Reuters - NEW YORK (Reuters Health) - In people with low blood levels of vitamin D, boosting them with supplements more than halved a person's risk of dying from any cause compared to someone who remained deficient, in a large new study. Analyzing data on more than 10,000 patients, University of Kansas researchers found that 70 percent were deficient in vitamin D and they were at significantly higher risk for a variety of heart diseases. D-deficiency also nearly doubled a person's likelihood of dying, whereas correcting the deficiency with supplements lowered their risk of death by 60 percent. ... Full Story | Top |
Mediterranean-ish diet tied to better heart health
Fri,25 Nov 2011 03:43 PM PST
Reuters - NEW YORK (Reuters Health) - Once again, eating a diet based on fish, legumes, vegetables and moderate amounts of alcohol is linked to lower chances of dying from a heart attack, stroke or other vascular "events," according to a new study of New York City residents. ...
Full Story | Top |
Ex-Olympus CEO says willing but not begging to return
Fri,25 Nov 2011 01:38 PM PST
Reuters -  TOKYO (Reuters) - The British ex-CEO of Japan's Olympus Corp emerged from a frosty meeting of directors on Friday convinced its board would eventually quit over an accounting scandal engulfing the firm, but he said he wasn't "begging" to return and clean up the mess. Michael Woodford, still an Olympus director despite being fired as CEO and blowing the whistle over the scam, described the meeting as a tense encounter with no handshakes or apologies offered from the men who had sacked him barely a month ago. ...
Full Story | Top |
FDA accepts marketing application of Amarin's heart
Fri,25 Nov 2011 09:09 AM PST
Reuters - (Reuters) - Biopharmaceutical company Amarin Corp said U.S. health regulators have accepted the marketing application for its heart pill and set an eight-month review period. Amarin shares, which have lost 44 percent in the last three months, rose 7 percent to $7.31 as U.S. Food and Drug Administration's decision kept alive the company's hope of finding a suitor. Roth Capital Partners analyst Joseph Pantginis, who was expecting this decision, recommended buying Amarin shares based on strong late-stage trial results and possible acquisition. ... Full Story | Top |
Aspirin not worth risks for healthy women: study
Fri,25 Nov 2011 05:06 AM PST
Reuters -  NEW YORK (Reuters Health) - Aspirin is a bad bargain for healthy women trying to stave off heart attacks or strokes, although it's commonly used for that purpose, according to Dutch researchers. In a new report, they say 50 women will need to take the medication for 10 years for just one to be helped -- and that's assuming they are at high risk to begin with. "There are very few women who actually benefit," said Dr. Jannick Dorresteijn of University Medical Center Utrecht in The Netherlands. ...
Full Story | Top |
| |
|
No comments:
Post a Comment